Long-term single-dose efficacy of a vesicular Stomatitis virus-based Andes virus vaccine in Syrian hamsters

Viruses

Volumn 6, Issue 2, 2014, Pages 516-523

  Prescott, Joseph ^a   Debuysscher, Blair L ^a,b   Brown, Kyle S ^c   Feldmann, Heinz ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MONTANA   (United States)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Andes virus; Antibody response; Durability; Hantavirus; Vaccine

Indexed keywords

UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS BASED ANDES VIRUS VACCINE; VIRUS VACCINE;

ANDES VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HANTAVIRUS CARDIOPULMONARY SYNDROME; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; SINGLE DRUG DOSE; VACCINATION; VESICULAR STOMATITIS VIRUS INFECTION; VIRUS; VIRUS INFECTION; VIRUS NEUTRALIZATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CRICETINAE; DRUG CARRIERS; FEMALE; HANTAVIRUS; HANTAVIRUS INFECTIONS; MESOCRICETUS; TIME FACTORS; VACCINES, SYNTHETIC; VESICULOVIRUS; VIRAL VACCINES;

EID: 84893339146     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v6020516     Document Type: Article

References (15)

1. Khan, A.S.; Ksiazek, T.G.; Peters, C.J. Hantavirus pulmonary syndrome. Lancet 1996, 347, 739-741.
2. Levis, S.; Rowe, J.E.; Morzunov, S.; Enria, D.A.; St Jeor, S. New hantaviruses causing hantavirus pulmonary syndrome in central Argentina. Lancet 1997, 349, 998-999.
3. Padula, P.J.; Edelstein, A.; Miguel, S.D.; López, N.M.; Rossi, C.M.; Rabinovich, R.D. Hantavirus pulmonary syndrome outbreak in Argentina: Molecular evidence for person-to-person transmission of Andes virus. Virology 1998, 241, 323-330.
4. Martinez, V.P.; Bellomo, C.; San Juan, J.; Pinna, D.; Forlenza, R.; Elder, M.; Padula, P.J. Person-to-person transmission of Andes virus. Emerg. Infect. Dis. 2005, 11, 1848-1853.
5. Lázaro, M.E.; Cantoni, G.E.; Calanni, L.M.; Resa, A.J.; Herrero, E.R.; Iacono, M.A.; Enria, D.A.; González Cappa, S.M. Clusters of hantavirus infection, southern Argentina. Emerg. Infect. Dis. 2007, 13, 104-110.
6. Hooper, J.W.; Larsen, T.; Custer, D.M.; Schmaljohn, C.S. A lethal disease model for hantavirus pulmonary syndrome. Virology 2001, 289, 6-14.
7. Safronetz, D.; Zivcec, M.; Lacasse, R.; Feldmann, F.; Rosenke, R.; Long, D.; Haddock, E.; Brining, D.; Gardner, D.; Feldmann, H.; et al. Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus. PLoS Pathog. 2011, 7, e1002426.
8. Brown, K.S.; Safronetz, D.; Marzi, A.; Ebihara, H.; Feldmann, H. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus. J. Virol. 2011, 85, 12781-12791.
9. Jones, S.M.; Feldmann, H.; Ströher, U.; Geisbert, J.B.; Fernando, L.; Grolla, A.; Klenk, H.-D.; Sullivan, N.J.; Volchkov, V.E.; Fritz, E.A.; et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 2005, 11, 786-790.
10. Prescott, J.; Safronetz, D.; Haddock, E.; Robertson, S.; Scott, D.; Feldmann, H. The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster. Immunology 2013, 140, 168-178.
11. Safronetz, D.; Ebihara, H.; Feldmann, H.; Hooper, J.W. The Syrian hamster model of hantavirus pulmonary syndrome. Antivir. Res. 2012, 95, 282-292.
12. Hooper, J.W.; Josleyn, M.; Ballantyne, J.; Brocato, R. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS). Vaccine 2013, 31, 4314-4321.
13. Kapadia, S.U.; Rose, J.K.; Lamirande, E.; Vogel, L.; Subbarao, K.; Roberts, A. Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. Virology 2005, 340, 174-182.
14. Schwartz, J.A.; Buonocore, L.; Suguitan, A.L.; Silaghi, A.; Kobasa, D.; Kobinger, G.; Feldmann, H.; Subbarao, K.; Rose, J.K. Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge. J. Virol. 2010, 84, 4611-4618.
15. Botten, J.; Mirowsky, K.; Kusewitt, D.; Bharadwaj, M.; Yee, J.; Ricci, R.; Feddersen, R.M.; Hjelle, B. Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus). Proc. Natl. Acad. Sci. USA 2000, 97, 10578-10583.